Trial Profile
A phase II/III trial of apogenix companion diagnostic in patients with glioblastoma.
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Asunercept (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
- 29 Jul 2015 New trial record